CELLUPHASE (50mL)

CELLUPHASE (50mL)

CELLUPHASE (50mL)
(20 amp. of base solution of 2mL, 2 vial Activator of 5mL)
 

  • Actives caffeine, taurine, L-Carnitine, Hamamelis, coumarin, rutin, silicon, mannitol 
  • Indications face liposculpture
  • Results face reshaping
  • Mesoteraphy

 

Mesoteraphy

See corresponding mesoskinline+ product (here)
You must be logged in to be able to see prices and place orders. You can create a user login under "MY ACCOUNT"
Stock status: In stock
Model/Product no.: DTG128

WORLDWIDE SHIPPING

We ship WorldWide every day

Fast delivery WorldWide

If you order before 4pm

Customer service and support

Call us at
(+45) 71741108

Certified products

Produced in the EU

CELLUPHASE


Few sessions to delete double chin, cheek, blepharo and bag eyes


 

Presentation
Box contains:
- n. 20 ampoules of CelluPhase Base Solution of 2.0mL e.a.
- n. 2 vials of CelluPhase Activator of 5.0mL e.a.
Celluphase is a meso-cocktail whose formula has been based on the basic premise of understanding correctly the face's localized adiposity and "orange peel" problems.
Facial adiposity is a process where multiple factors intervene which are statistically associated with its presence and predispose towards its appearance: endocrine, enzymatic, psychosomatic, genetic, dietetic, mechanical and vascular.



Use
Two Base Solution Ampoules with 1mL of Activator Celluphase per session beginning with one per week for 4 to 6 weeks. Continue with fortnightly sessions, ending with a monthly application.



Results
Contains five individually clinically proven actives at increased concentrations, where other treatments only contain one;
Remodels and re-firms face;
Accelerates natural subcutaneous fat diminishment mechanisms;
Smooths and tightens the skin;
Reduces the 'orange peel' effect by improving microcirculation;
Celluphase has a Firming Effect on the skin, which when measured by ballistometry, showed a 9.5% decrease in indentation in the skin and a 27.5% decrease in skin flaccidity reduces Double Chin by up to 80%.